The role of anemia on admission in acute coronary syndrome - An umbrella review of systematic reviews and meta-analyses.

[1]  S. Anker,et al.  Safety and efficacy of iron supplementation after myocardial infarction in mice with moderate blood loss anaemia , 2021, ESC heart failure.

[2]  V. Pineda,et al.  Implications of Iron Deficiency in STEMI Patients and in a Murine Model of Myocardial Infarction , 2021, JACC. Basic to translational science.

[3]  Jun Ren,et al.  Dysregulation of Iron Metabolism in Cardiovascular Diseases: from Iron Deficiency to Iron Overload. , 2021, Biochemical pharmacology.

[4]  E. Vicaut,et al.  Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial. , 2021, JAMA.

[5]  C. Papadopoulou,et al.  Iron deficiency for prognosis in acute coronary syndrome - A systematic review and meta-analysis. , 2020, International journal of cardiology.

[6]  M. Muckenthaler,et al.  Iron deficiency , 2020, The Lancet.

[7]  A. Lazou,et al.  The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection , 2020, International journal of molecular sciences.

[8]  J. Fischer,et al.  Anaemia is associated with severe RBC dysfunction and a reduced circulating NO pool: vascular and cardiac eNOS are crucial for the adaptation to anaemia , 2020, Basic Research in Cardiology.

[9]  P. Lei,et al.  The pathological role of ferroptosis in ischemia/reperfusion-related injury , 2020, Zoological research.

[10]  S. Blankenberg,et al.  Iron deficiency is a common disorder in general population and independently predicts all-cause mortality: results from the Gutenberg Health Study , 2020, Clinical Research in Cardiology.

[11]  G. Pontone,et al.  Iron deficiency in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. , 2020, International journal of cardiology.

[12]  G. Guyatt,et al.  Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine , 2020, Intensive Care Medicine.

[13]  L. Räber,et al.  Prognosis of Patients with Chronic and Hospital-Acquired Anaemia After Acute Coronary Syndromes , 2019, Journal of Cardiovascular Translational Research.

[14]  T. Ganz.  Anemia of Inflammation. , 2019, The New England journal of medicine.

[15]  D. Erlinge,et al.  Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE‐SWEDEHEART Trial , 2019, Journal of the American Heart Association.

[16]  M. Valdés,et al.  Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome. , 2019, European journal of internal medicine.

[17]  P. Ponikowski,et al.  Iron Deficiency in Heart Failure: An Overview. , 2019, JACC. Heart failure.

[18]  C. Östenson,et al.  Erythrocytes From Patients With Type 2 Diabetes Induce Endothelial Dysfunction Via Arginase I. , 2018, Journal of the American College of Cardiology.

[19]  M. Totzeck,et al.  Red blood cell transfusion in patients with ST-elevation myocardial infarction—a meta-analysis of more than 21,000 patients , 2018, Netherlands Heart Journal.

[20]  L. Svensson,et al.  Oxygen therapy in ST-elevation myocardial infarction , 2018, European heart journal.

[21]  S. Savonitto,et al.  Anemia and acute coronary syndrome: current perspectives , 2018, Vascular health and risk management.

[22]  Yi-tong Ma,et al.  Effects of erythropoietin on the clinical outcomes of patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A meta-analysis
. , 2018, International journal of clinical pharmacology and therapeutics.

[23]  D. Stub,et al.  Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta-analysis of randomised clinical trials , 2018, Heart.

[24]  Yucheng Chen,et al.  Impact of red blood cell transfusion on acute coronary syndrome: a meta-analysis , 2018, Internal and Emergency Medicine.

[25]  M. Gladwin,et al.  Erythrocytes and Vascular Function: Oxygen and Nitric Oxide , 2018, Front. Physiol..

[26]  I. Komuro,et al.  Low-Dose Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction (EPO-AMI-II)　- A Randomized Controlled Clinical Trial. , 2018, Circulation journal : official journal of the Japanese Circulation Society.

[27]  S. Bagshaw,et al.  Restrictive or Liberal Red‐Cell Transfusion for Cardiac Surgery , 2017, The New England journal of medicine.

[28]  T. Hervig,et al.  Microcirculation and red cell transfusion in patients with sepsis. , 2017, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[29]  D. Triulzi,et al.  Indications for and Adverse Effects of Red-Cell Transfusion. , 2017, The New England journal of medicine.

[30]  R. Bellomo,et al.  Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults , 2017, The New England journal of medicine.

[31]  P. Tugwell,et al.  AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both , 2017, British Medical Journal.

[32]  Weisheng Liu,et al.  Blood transfusion and mortality in myocardial infarction: an updated meta-analysis. , 2017, Oncotarget.

[33]  Yucheng Chen,et al.  Restrictive versus liberal blood transfusion in patients with coronary artery disease: a meta-analysis , 2017, Current medical research and opinion.

[34]  W. Chey,et al.  ACG Clinical Guideline: Treatment of Helicobacter pylori Infection , 2017, The American Journal of Gastroenterology.

[35]  Sunil V. Rao,et al.  Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. , 2016, JAMA.

[36]  I. Buchan,et al.  Relationship Between Anemia and Mortality Outcomes in a National Acute Coronary Syndrome Cohort: Insights From the UK Myocardial Ischemia National Audit Project Registry , 2016, Journal of the American Heart Association.

[37]  Richard J Cook,et al.  Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion. , 2016, The New England journal of medicine.

[38]  M. Radford,et al.  Provoking conditions, management and outcomes of type 2 myocardial infarction and myocardial necrosis. , 2016, International journal of cardiology.

[39]  R. Bartlett,et al.  Anemia and Transfusion in Critical Care , 2016, Journal of intensive care medicine.

[40]  M. Basora,et al.  Restrictive versus liberal transfusion strategy for red blood cell transfusion in critically ill patients and in patients with acute coronary syndrome: a systematic review, meta-analysis and trial sequential analysis. , 2016, Minerva anestesiologica.

[41]  Hanan Khalil,et al.  Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach , 2015, International journal of evidence-based healthcare.

[42]  T. Walsh,et al.  Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial , 2015, The Lancet.

[43]  F. Sedaghat-Hamedani,et al.  Administration of erythropoietin in patients with myocardial infarction: does it make sense? An updated and comprehensive meta-analysis and systematic review. , 2015, Cardiovascular revascularization medicine : including molecular interventions.

[44]  U. Sechtem,et al.  Positive effect of intravenous iron-oxide administration on left ventricular remodelling in patients with acute ST-elevation myocardial infarction - a cardiovascular magnetic resonance (CMR) study , 2014, Journal of Cardiovascular Magnetic Resonance.

[45]  C. Natanson,et al.  Does prolonged storage of red blood cells cause harm? , 2014, British journal of haematology.

[46]  Jingyan Xu,et al.  High-Dose Erythropoietin in Acute ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials , 2013, American Journal of Cardiovascular Drugs.

[47]  K. Filion,et al.  Red blood cell transfusion and mortality among patients hospitalized for acute coronary syndromes: a systematic review. , 2013, International journal of cardiology.

[48]  K. Filion,et al.  Anemia and mortality in acute coronary syndromes: a systematic review and meta-analysis. , 2013, American heart journal.

[49]  J. Wetterslev,et al.  Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. , 2013, JAMA internal medicine.

[50]  X. Niu,et al.  Erythropoietin treatment in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials. , 2012, American heart journal.

[51]  Junfeng Sun,et al.  Transfusion of older stored blood and risk of death: a meta‐analysis , 2012, Transfusion.

[52]  Juan Li,et al.  Effect of erythropoiesis-stimulating agents in acute ST-segment elevation myocardial infarction: a systematic review , 2012, European Journal of Clinical Pharmacology.

[53]  A. Dart,et al.  Effect of Iron Chelation on Myocardial Infarct Size and Oxidative Stress in ST-Elevation–Myocardial Infarction , 2012, Circulation. Cardiovascular interventions.

[54]  E. Belle,et al.  Prognostic value of hemoglobin decline over the GRACE score in patients hospitalized for an acute coronary syndrome , 2012, Heart and Vessels.

[55]  Jun Zhu,et al.  Anaemia and Prognosis in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis , 2012, The Journal of international medical research.

[56]  R. Sprague,et al.  Erythrocytes as controllers of perfusion distribution in the microvasculature of skeletal muscle , 2011, Acta physiologica.

[57]  L. Ferrucci,et al.  Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. , 2011, JAMA.

[58]  S. Anker,et al.  A single dose of erythropoietin in ST-elevation myocardial infarction. , 2010, European heart journal.

[59]  P. Armstrong,et al.  Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. , 2009, European heart journal.

[60]  A. Voors,et al.  Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients. , 2008, European heart journal.

[61]  Richard B. Thompson,et al.  A novel protective effect of erythropoietin in the infarcted heart. , 2003, The Journal of clinical investigation.

[62]  E. Lakatta,et al.  Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[63]  A. D. Black,et al.  Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. , 2003, Biochemical and biophysical research communications.

[64]  H. Corey.  Stewart and beyond: new models of acid-base balance. , 2003, Kidney international.

[65]  G. Semenza,et al.  Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia‐Reperfusion Injury , 2003, Circulation.

[66]  K. Maiese,et al.  Angiogenesis and plasticity: role of erythropoietin in vascular systems. , 2002, Journal of hematotherapy & stem cell research.

[67]  A. Anagnostou,et al.  Erythropoietin receptor mRNA expression in human endothelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[68]  G. W. James,et al.  The Heart in Anemia , 1953, Circulation.

[69]  P. Harst,et al.  Relation of Iron Status to Prognosis After Acute Coronary Syndrome , 2022 .

[70]  J. Detterich,et al.  Nitric oxide, vasodilation and the red blood cell. , 2014, Biorheology.